Literature DB >> 16307792

Thin endometrial echo complex on ultrasound does not reliably exclude type 2 endometrial cancers.

Jing Wang1, Cecilia Wieslander, Gail Hansen, Ilana Cass, Steven Vasilev, Christine H Holschneider.   

Abstract

OBJECTIVE: The objective of this study was to determine the ultrasonographic characteristics of the uterus and endometrial echo-complex (EEC) of postmenopausal patients diagnosed with type 2 endometrial cancer, including uterine papillary serous carcinoma (UPSC), clear cell carcinoma (CCC), and other endometrial high-grade carcinomas (HGC).
METHODS: Postmenopausal patients with type 2 endometrial cancer who underwent preoperative pelvic ultrasound were identified. Histologic diagnoses were made by biopsy or hysterectomy. Ultrasound reports were abstracted for the following parameters: EEC thickness, presence of intracavitary fluid or lesion, myometrial mass, uterine size, and adnexal mass. Ultrasound films were re-reviewed by a single gynecologic ultrasonographer.
RESULTS: Fifty-two patients with detailed ultrasound reports comprised the study population. Twenty-six films were available for re-review and inter-examiner agreement was 92%. Forty-four women (85%) presented with abnormal vaginal bleeding. Thirty-four patients (65%) had a thickened EEC measuring >5 mm. In 9 cases (17%), the EEC measured <4 mm. In an additional 9 patients (17%) the EEC was indistinct. One or more other ultrasound abnormalities were found in each of the 18 cases with a non-thickened EEC: intracavitary fluid or lesion (8; 44%), myometrial mass (12; 67%), enlarged uterus (13; 72%), or adnexal mass (5; 28%).
CONCLUSION: A thin or indistinct endometrial stripe, especially when associated with other ultrasound abnormalities does not reliably exclude type 2 endometrial cancer. Postmenopausal vaginal bleeding requires endometrial sampling despite a thin EEC in the presence of other ultrasonographic abnormalities or persistent bleeding.

Entities:  

Mesh:

Year:  2005        PMID: 16307792     DOI: 10.1016/j.ygyno.2005.09.042

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  12 in total

1.  Role of spiral artery Doppler to screen type 2 endometrial cancer cases.

Authors:  Soner Düzgüner; Mehmet Burak Ozkan; Tuncay Küçüközkan; Enis Ozkaya; Fadıl Kara; Ipek Nur Balın; Vakkas Korkmaz; Mehmet Fatih Karslı; Burak Gültekin
Journal:  J Turk Ger Gynecol Assoc       Date:  2014-03-01

Review 2.  Thickened Endometrium: When to Intervene? A Clinical Conundrum.

Authors:  S K Giri; B L Nayak; Janmejay Mohapatra
Journal:  J Obstet Gynaecol India       Date:  2021-02-02

Review 3.  Beyond Serous: Treatment Options for Rare Endometrial Cancers.

Authors:  Erin Crane
Journal:  Curr Treat Options Oncol       Date:  2022-10-07

Review 4.  Controversies in the Management of Early-stage Serous Endometrial Cancer.

Authors:  Alyssa Larish; Andrea Mariani; Carrie Langstraat
Journal:  In Vivo       Date:  2021 Mar-Apr       Impact factor: 2.155

5.  The Impact of Fibroids and Histologic Subtype on the Performance of US Clinical Guidelines for the Diagnosis of Endometrial Cancer among Black Women.

Authors:  Sarah S Romano; Kemi M Doll
Journal:  Ethn Dis       Date:  2020-09-24       Impact factor: 1.847

6.  Association of Endometrial Cancer Risk With Postmenopausal Bleeding in Women: A Systematic Review and Meta-analysis.

Authors:  Megan A Clarke; Beverly J Long; Arena Del Mar Morillo; Marc Arbyn; Jamie N Bakkum-Gamez; Nicolas Wentzensen
Journal:  JAMA Intern Med       Date:  2018-09-01       Impact factor: 21.873

7.  Endometrial cancer.

Authors:  Mara Sobel; Andrea N Simpson; Sarah E Ferguson
Journal:  CMAJ       Date:  2021-09-13       Impact factor: 8.262

8. 

Authors:  Mara Sobel; Andrea N Simpson; Sarah E Ferguson
Journal:  CMAJ       Date:  2021-11-15       Impact factor: 8.262

9.  Non-invasive detection of endometrial cancer by DNA methylation analysis in urine.

Authors:  Rianne van den Helder; Birgit M M Wever; Nienke E van Trommel; Annina P van Splunter; Constantijne H Mom; Jenneke C Kasius; Maaike C G Bleeker; Renske D M Steenbergen
Journal:  Clin Epigenetics       Date:  2020-11-03       Impact factor: 6.551

10.  First-stage clear-cell endometrial carcinoma with paraaortic lymph node recurrence: a case report.

Authors:  Strahil Asenov Strashilov; Stanislav Slavchev; Stoyan Kostov; Angel Yordanov
Journal:  Prz Menopauzalny       Date:  2021-04-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.